4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Zura Bio Limited (ZURA) operates in the Biotechnology industry and is headquartered in Henderson, United States with about 40 employees. Its market capitalization is roughly $523 million. In the fiscal year ended 2025-12-31, ZURA reported $0M in revenue and ($69M) in net income.
Zura Bio Limited, a clinical-stage biotechnology company, develops medicines for autoimmune and inflammatory disorders in the United States.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($75M) | ($55M) | ($63M) | ($27M) |
| Net Income | ($69M) | ($52M) | ($60M) | ($26M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($26M) | ($18M) | ($20M) | ($18M) | ($19M) | — |
| Net Income | ($24M) | ($17M) | ($18M) | ($16M) | ($17M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-03-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Total Assets | $114M | $180M | $101M | $5M | — | — |
| Total Liabilities | $12M | $20M | $21M | $27M | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ZURA viewer.
About TickerBase · Data methodology & sources